Form 4: Royalty Pharma Director Bonnie L. Bassler Acquires Shares in Lieu of Retainer

Bonnie L. Bassler, a director at Royalty Pharma plc, acquired 1,240 Class A Ordinary Shares on March 28, 2024, in lieu of a quarterly retainer payment.

Summary

• On March 28, 2024, Bonnie L. Bassler, a director of Royalty Pharma plc, acquired 1,240 Class A Ordinary Shares.
• The shares were acquired at a price of $30.2283 per share.
• This acquisition was made in lieu of a quarterly retainer payment of $37,500 under the Issuer's 2020 Independent Director Equity Incentive Plan.
• Following the transaction, Bassler directly owns 47,762 Class A Ordinary Shares.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard transaction related to director compensation. The director taking shares instead of cash could be seen as a slightly positive signal.

Positives

• The director's decision to take shares in lieu of cash may signal confidence in the company's future performance.

Future Outlook

No specific future outlook is provided in this document.

Industry Context

This is a routine disclosure related to director compensation and share ownership, common in publicly traded companies. It reflects a mechanism for compensating board members and aligning their interests with those of shareholders.

Related Party Transactions

• The issuance of shares to Bonnie L. Bassler, a director, in lieu of a cash retainer payment constitutes a related party transaction.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.

Key Dates